Enecadin

DB13032InvestigationalSmall molecule

Enecadin has been investigated for the treatment of Stroke.

Chemical structure of Enecadin
Formula / weight
C21H28FN3O · 357.473 g/mol (avg)

Resolves to

Compound
UNIIVR034VW8OGCAS259525-01-4ChEMBLCHEMBL29404PubChem6433114
Structure
InChIKeySZSHJTJCJOWMHM-UHFFFAOYSA-NSMILESCC1=NC(=CC(OCCCCCN2CCCCC2)=N1)C1=CC=C(F)C=C1

What you can answer from here — as of February 21, 2021

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Enecadin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In